Alopecia (Baldness)

05/01/2000 - "The best treatment option for women with androgenetic alopecia Ludwig stage I and II is minoxidil 5% solution. "
02/01/2002 - "After more than a decade of use, topical minoxidil solution has proven to be a safe and effective treatment for androgenetic alopecia. "
03/01/1994 - "Topical minoxidil was significantly more effective than placebo in the treatment of female androgenetic alopecia."
10/01/1993 - "Topical minoxidil solution was significantly more effective than placebo in the treatment of androgenetic alopecia in women."
05/01/1986 - "It was concluded that topical minoxidil has the potential to improve male pattern baldness significantly without apparent risk and to be a means by which individual presentation of self may be improved."

11/01/2014 - "Finasteride at a dose of 1 mg/d has been reported to show no significant improvement in 30-50% of patients with androgenetic alopecia (AGA). "
07/01/2015 - "In conclusion, continuous finasteride treatment for 5 years improved androgenetic alopecia with sustained effect among Japanese. "
01/01/2008 - "No study has shown that 1 mg of finasteride effectively treats female androgenetic alopecia but doses of 2.5 and 5 mg finasteride have helped some women in a few open studies. "
05/01/2008 - "Finasteride is a 5alpha-reductase inhibitor that has proved to be an effective treatment for men with androgenetic alopecia. "
08/01/2002 - "Finasteride 1 mg/day is effective in the treatment of androgenetic alopecia (AGA). "

11/01/1990 - "This led to a partial remission of two-years duration and the abatement of a doxorubicin-induced alopecia. "
10/01/1996 - "The present studies were undertaken to topographically localize the site of injury in the hair follicle after doxorubicin (DXR) administration and to investigate the mechanism of DXR-induced alopecia. "
10/01/1986 - "Preliminary studies are reported on the effectiveness of cold air scalp cooling to prevent alopecia in patients receiving Adriamycin. "
07/01/2015 - "Nonpegylated liposomal doxorubicin: reduction in cardiotoxicity, although still severe alopecia."
04/01/2006 - "Doxorubicin-induced alopecia is associated with sebaceous gland degeneration."

08/01/2001 - "PTH(7-34) and PTHrP(7-34) shifted it towards a mild form of "dystrophic anagen", associated with a significant reduction in apoptotic (TUNEL+) hair bulb cells, thus mitigating the degree of follicle damage and retarding the onset of cyclophosphamide-induced alopecia. "
01/01/1987 - "Good results were obtained though the course included cyclophosphamide which also causes alopecia. "
01/01/2014 - "Cyclophosphamide (125 mg/kg) was used to induce alopecia. "
01/01/2014 - "in treatment of cyclophosphamide induced alopecia."
01/01/2013 - "Our data provide a rationale for exploring suppression of translation initiation as an approach to prevent or minimize cyclophosphamide-induced alopecia."

07/01/1991 - "In the present study, using the young rat model, recombinant human IL 1 beta produced excellent protection from cytosine arabinoside-induced alopecia. "
10/01/2009 - "However, the AHCC (p.o.)-treated Ara-C group was significantly protected from alopecia. "
10/01/2009 - "Of the Ara-C treated rats 71.4% showed severe alopecia and 28.6% showed moderate alopecia. "
11/01/1992 - "All rates treated with ARA-C alone developed complete body alopecia. "
01/15/1992 - "In other experiments the administration of acidic FGF (aFGF) with ARA-C resulted in protection from alopecia limited to the site of FGF injection. "

01/01/1989 - "The therapeutic results warrant the conclusion that cyproterone acetate seems to be effective in androgenetic alopecia in women."
01/01/1989 - "The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females."
12/01/2002 - "We report a 66-year-old lady taking 50 mg/day of cyproterone acetate for biopsy proven androgenetic alopecia, who developed this unusual complication of shortness of breath. "
12/01/2002 - "Shortness of breath: an uncommon side-effect of cyproterone acetate in the treatment of androgenetic alopecia."
01/01/2002 - "While androgenetic alopecia is best treated with a low-dose OC containing cyproterone acetate (optimal effect occurs after at least 12 months of therapy), severe acne and hirsutism are significantly improved after 6-12 months of regimens containing high doses of cyproterone acetate (25-100 mg/day). "

11/01/2015 - "niruri might be useful in the treatment of testosterone-induced alopecia in the experimental animal by inhibiting 5α-reductase enzyme."
05/01/2013 - "The purpose of this study was to investigate the potential contribution of environmental factors and testosterone on male alopecia. "
12/01/2012 - "In this study, the authors investigated the potential contribution of environmental factors and testosterone levels on androgenic alopecia in women. "
04/01/2011 - "This was a prospective randomised study of five male consultant maxillofacial surgeons (including two with male pattern baldness) and assayed serum testosterone levels at rest, during, and after a series of major ablative and reconstructive procedures. "
11/01/1975 - "The action of testosterone as an incitant in male pattern baldness is well known, but this study points out the continued effect of time, even in later years. "

02/01/1992 - "Both ImuVert and IL 1 were equally effective in protecting rats from ARA-C-induced alopecia. "
07/01/1991 - "It is concluded that the protection from alopecia by ImuVert is mediated by cytokines, primarily IL 1."
07/01/1991 - "Protection from cytosine arabinoside-induced alopecia by ImuVert has recently been reported in a rat model. "
09/28/1990 - "In recent work on the treatment of myelogenous leukemia in the rat, the following observations were made: (i) treatment of 8-day-old rats with cytosine arabinoside consistently produced alopecia, and (ii) ImuVert, a biologic response modifier derived from the bacterium Serratia marcescens, uniformly produced complete protection against the alopecia. "
02/01/1992 - "ImuVert, a biologic response modifier, and interleukin 1 (IL 1) have been shown to protect the young rat from alopecia induced by cytarabine (ARA-C). "

10/01/2015 - "Treatment with oral ciclosporin resulted in near complete resolution of the alopecia, but after 5 months without treatment the alopecia did not relapse and spontaneous resolution cannot be ruled out."
12/01/2010 - "The objective of this multicentre, partly double-blinded, randomized controlled study was to evaluate the efficacy of ciclosporin A, either alone or with topical therapy, in comparison to conventional topical treatment alone, as measured by the primary end-points alopecia and scaling, and multiple histopathological secondary objectives. "
02/01/1990 - "The aim of this study was to determine whether topical cyclosporine affects male pattern alopecia. "
11/01/2001 - "Oral cyclosporin does not arrest progression of androgenetic alopecia."
02/01/1990 - "Topical cyclosporine in male pattern alopecia."

06/01/2013 - "Erratum to: Clinical Efficacy of a Cosmetic Treatment by Crescina(®) Human Follicle Stem Cell on Healthy Males with Androgenetic Alopecia."
06/01/2013 - "Clinical efficacy of a cosmetic treatment by Crescina(®) human follicle stem cell on healthy males with androgenetic alopecia."
08/01/2015 - " safety findings over all clinical studies (study references B to E) matched those already described for the respective products and included transient cosmetic changes (oily hair and crystal formation) at the site of spot-on application and broken hair, transient alopecia and skin alterations at the site of collar application. "
12/01/2015 - "Moreover, most literature on age-related hair changes focuses on alopecia, but it is equally important that the hair fibers that emerge from the scalp exhibit significant age-related changes that have equal impact on the overall cosmetic properties of hair. "
05/01/2015 - "Cicatricial alopecia is a form of hair loss that causes both cosmetic and psychological concerns. "

01/01/2014 - "This study compared the efficacy of prophylactic versus therapeutic administration of PTH-CBD in chemotherapy-induced alopecia using a mouse model that mimics the cyclic chemotherapy dosing used clinically. "
03/01/2015 - "Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis."
11/01/2014 - "Alopecia usually cannot be cured because of the available drug therapy being unsatisfactory. "
07/01/2013 - "In order to evaluate the efficacy of scalp cooling for the prevention of chemotherapy-induced alopecia (CIA), it is essential to precisely quantify the amount of hair mass that is present. "
11/01/2011 - "Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy."

01/01/2011 - "A significant reduction in excoriation and alopecia subscores was observed 6 weeks after treatment (39.9%, P < 0.05 and 19.9%, P < 0.05, resp.). "
09/01/2002 - "The aim of the study was to carry out clinical and trichological examination (trichogram and assessment of hair loss) before and after treatment in 17 women aged 41-50 years with androgenic alopecia. "
03/01/2015 - "The occurrence of long-term alopecia at hair-bearing sites after treatment with PDL may be greater than previously thought. "
12/01/2013 - "After treatment, no SLE patients had relapse of alopecia, while 41.7% of AA patients did. "
02/01/2011 - "Severity grading of AA was carried out using the Severity of Alopecia Tool (SALT) score before and after treatment. "

02/15/2006 - "Compared with VAd, DVd also significantly decreased the need for central venous access (P < 0.0001) and growth-factor support (P = 0.03) and resulted in less alopecia (20% vs. 44%; P < 0.001) but more hand-foot syndrome (25% vs. 1%; P < 0.001), mainly Grade 1/2. The DVd regimen demonstrated similar efficacy with less toxicity and supportive care compared with VAd, which should improve clinical utility and optimize the opportunity for transplantation."
01/01/2014 - "To investigate the efficacy of follicular unit transplantation in the treatment of cicatricial alopecia in Chinese patients. "
01/01/2014 - "However, large-scale clinical trials are necessary to study follicular unit transplantation for treating Chinese cicatricial alopecia patients. "
09/01/2002 - "Study III: An observational study was done in 12 patients with androgenetic alopecia about 1 year after transplantation of occipital hair to frontal scalp. "
07/01/1986 - "The authors present a study of 150 patients treated for male pattern alopecia by autograft punch transplantation. "

10/01/2005 - "The improved scalp coverage achieved by hair transplant for men with androgenetic alopecia can be diminished by continued miniaturization and loss of preexisting, nontransplanted hairs. "
11/01/1991 - "To minimize this problem, we introduced and improved a new procedure for the treatment of pattern baldness by using microsurgical hair grafts taken from the occipital region. "
05/01/1995 - "Effect of skin-graft harvesting on hair growth; implications for the study of alopecia."
08/01/2013 - "Hair transplant surgery is extremely successful in correcting the most cosmetically problematic areas of alopecia. "
05/01/2013 - "Aesthetic correction of cicatricial sideburn alopecia using follicular-unit hair grafts."

10/01/2014 - "LLLT of the scalp at 655 nm significantly improved hair counts in women with androgenetic alopecia at a rate similar to that observed in males using the same parameters."
10/01/2013 - "LLLT of the scalp at 655 nm significantly improved hair counts in males with androgenetic alopecia."
05/01/2015 - "The published studies on alopecia did not show that LLLT had efficacy for this indication, and on skin aging only two studies are reported showing that LLLT globally improved aging of skin. "
04/01/2014 - "A handful of studies have since investigated the efficacy of LLLT for alopecia with mixed results. "
02/01/2015 - "Efficacy of low-level laser therapy on hair regrowth in dogs with noninflammatory alopecia: a pilot study."